-
Something wrong with this record ?
Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism
L. Borek-Dohalska, Z. Klusonova, J. Holecova, M. Martinkova, F. Barta, H. Dracinska, T. Cajthaml, M. Stiborova,
Language English Country Sweden
Document type Journal Article
PubMed
28263535
Knihovny.cz E-resources
- MeSH
- Benzo(a)pyrene pharmacology MeSH
- Endocrine Disruptors pharmacology MeSH
- Estradiol pharmacology MeSH
- Estrogens pharmacology MeSH
- Ethinyl Estradiol pharmacology MeSH
- Microsomes, Liver metabolism MeSH
- Rats MeSH
- Rats, Wistar MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: The term "endocrine disruptor" (ED) is used for compounds that mimic or antagonize the effects of endogenous hormones. Synthetic estrogen 17α-ethinylestradiol (EE2) and a human carcinogen benzo[a]pyrene (BaP) are assigned as exogenous endocrine disruptors and an estrogenic hormone estradiol is a natural endogenous disruptor. Here, the potency of these three disruptors administered to rats individually and in combination to induce expression of cytochrome P450 (CYP) enzymes involved in their own metabolism (CYP1A1, 2C and 3A) in vivo was investigated. METHODS: Changes in CYP protein expression after exposure of rats to BaP, EE2 or estradiol were analyzed by Western blotting. Using the HPLC method, CYP1A1, 2C and 3A specific activities in hepatic microsomes isolated from exposed rats were analyzed. RESULTS: Whereas exposure to BaP induces expression of CYP1A1 protein and its marker activity (Sudan I oxidation) in liver, kidney and lung of rats, no significant induction of this CYP and its enzyme activity was produced by EE2 and estradiol. Treatment of BaP in combination with EE2 and/or estradiol decreased the BaP-mediated CYP1A1 induction in liver of exposed rats. BaP also induces CYP2C11 protein in rat liver and kidney, but does not increase its enzyme activity measured as testosterone 16α-hydroxylation. The enzyme activity of another enzyme of the 2C subfamily, CYP2C6, diclofenac 4'-hydroxylation, is even decreased by BaP. The CYP2C11 protein expression and/or its activity are also increased in liver of rats treated with EE2 and estradiol, but its expression is significantly decreased in lung. The CYP2C6 activity is also elevated by treatment of rats with EE2 and estradiol administered individually as well as in their combination. Whereas only a slight increase in CYP3A protein expression was found by BaP in rat liver, its enzyme activity, testosterone 6β-hydroxyalation, increased significantly in this organ. In contrast, no effect or even a decrease in CYP3A expression and its enzyme activity was produced by EE2 and estradiol in rats exposed to these compounds.
Department of Biochemistry Faculty of Science Charles University Prague 2 Czech Republic
Institute of Microbiology Academy of Science of the Czech Republic Prague 4 Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023228
- 003
- CZ-PrNML
- 005
- 20250423153145.0
- 007
- ta
- 008
- 170720s2016 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)28263535
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Borek-Dohalska, Lucie $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 245 10
- $a Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism / $c L. Borek-Dohalska, Z. Klusonova, J. Holecova, M. Martinkova, F. Barta, H. Dracinska, T. Cajthaml, M. Stiborova,
- 520 9_
- $a OBJECTIVES: The term "endocrine disruptor" (ED) is used for compounds that mimic or antagonize the effects of endogenous hormones. Synthetic estrogen 17α-ethinylestradiol (EE2) and a human carcinogen benzo[a]pyrene (BaP) are assigned as exogenous endocrine disruptors and an estrogenic hormone estradiol is a natural endogenous disruptor. Here, the potency of these three disruptors administered to rats individually and in combination to induce expression of cytochrome P450 (CYP) enzymes involved in their own metabolism (CYP1A1, 2C and 3A) in vivo was investigated. METHODS: Changes in CYP protein expression after exposure of rats to BaP, EE2 or estradiol were analyzed by Western blotting. Using the HPLC method, CYP1A1, 2C and 3A specific activities in hepatic microsomes isolated from exposed rats were analyzed. RESULTS: Whereas exposure to BaP induces expression of CYP1A1 protein and its marker activity (Sudan I oxidation) in liver, kidney and lung of rats, no significant induction of this CYP and its enzyme activity was produced by EE2 and estradiol. Treatment of BaP in combination with EE2 and/or estradiol decreased the BaP-mediated CYP1A1 induction in liver of exposed rats. BaP also induces CYP2C11 protein in rat liver and kidney, but does not increase its enzyme activity measured as testosterone 16α-hydroxylation. The enzyme activity of another enzyme of the 2C subfamily, CYP2C6, diclofenac 4'-hydroxylation, is even decreased by BaP. The CYP2C11 protein expression and/or its activity are also increased in liver of rats treated with EE2 and estradiol, but its expression is significantly decreased in lung. The CYP2C6 activity is also elevated by treatment of rats with EE2 and estradiol administered individually as well as in their combination. Whereas only a slight increase in CYP3A protein expression was found by BaP in rat liver, its enzyme activity, testosterone 6β-hydroxyalation, increased significantly in this organ. In contrast, no effect or even a decrease in CYP3A expression and its enzyme activity was produced by EE2 and estradiol in rats exposed to these compounds.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benzopyren $x farmakologie $7 D001564
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a endokrinní disruptory $x farmakologie $7 D052244
- 650 _2
- $a estradiol $x farmakologie $7 D004958
- 650 _2
- $a estrogeny $x farmakologie $7 D004967
- 650 _2
- $a ethinylestradiol $x farmakologie $7 D004997
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x metabolismus $7 D008862
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Klusonova, Zuzana $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 700 1_
- $a Holecova, Jana $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 700 1_
- $a Martinkova, Marketa $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 700 1_
- $a Bárta, František $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic. $7 xx0331419
- 700 1_
- $a Dracinska, Helena $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 700 1_
- $a Cajthaml, Tomas $u Institute of Microbiology, Academy of Science of the Czech Republic, Prague 4, Czech Republic.
- 700 1_
- $a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro-endocrinology letters $x 0172-780X $g Roč. 37, Suppl1 (2016), s. 84-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28263535 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20250423153145 $b ABA008
- 999 __
- $a ok $b bmc $g 1238909 $s 984141
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 37 $c Suppl1 $d 84-94 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20170720